[Effects of intravenous administration of nitroglycerin and SIN-1 or molsidomine on epicardial arterial diameter in patients with stable coronary heart disease].
Münzel
T
T
Medizinische Klinik III, Universität Freiburg.
Kurz
S
S
Heitzer
T
T
Luhmann
C
C
Just
H
H
D003326:Coronary Circulation / Q000187:drug effects*; D003327:Coronary Disease / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D004361:Drug Tolerance; D006801:Humans; D007262:Infusions, Intravenous; D008981:Molsidomine / Q000008:administration & dosage* / Q000009:adverse effects / Q000031:analogs & derivatives*; D005996:Nitroglycerin / Q000008:administration & dosage* / Q000009:adverse effects; D014655:Vascular Resistance / Q000187:drug effects*; D014665:Vasodilator Agents / Q000008:administration & dosage* / Q000009:adverse effects
D014665:Vasodilator Agents; C002385:linsidomine; D008981:Molsidomine; D005996:Nitroglycerin
Auswirkungen einer intravenösen Gabe von Nitroglycerin bzw. SIN-1 oder Molsidomin auf den Epikardarteriendurchmesser bei Patienten mit stabiler koronarer Herzkrankheit.